75 related articles for article (PubMed ID: 23134667)
1. Inhibition of TGF-β signaling by the fungal lactones (S)-curvularin, dehydrocurvularin, oxacyclododecindione and galiellalactone.
Rudolph K; Serwe A; Erkel G
Cytokine; 2013 Jan; 61(1):285-96. PubMed ID: 23134667
[TBL] [Abstract][Full Text] [Related]
2. Clusterin, a novel modulator of TGF-beta signaling, is involved in Smad2/3 stability.
Lee KB; Jeon JH; Choi I; Kwon OY; Yu K; You KH
Biochem Biophys Res Commun; 2008 Feb; 366(4):905-9. PubMed ID: 18082619
[TBL] [Abstract][Full Text] [Related]
3. Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.
Tian F; Byfield SD; Parks WT; Stuelten CH; Nemani D; Zhang YE; Roberts AB
Cancer Res; 2004 Jul; 64(13):4523-30. PubMed ID: 15231662
[TBL] [Abstract][Full Text] [Related]
4. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling.
Brown KA; Pietenpol JA; Moses HL
J Cell Biochem; 2007 May; 101(1):9-33. PubMed ID: 17340614
[TBL] [Abstract][Full Text] [Related]
5. Geldanamycin inhibits TGF-beta signaling through induction of Hsp70.
Yun CH; Yoon SY; Nguyen TT; Cho HY; Kim TH; Kim ST; Kim BC; Hong YS; Kim SJ; Lee HJ
Arch Biochem Biophys; 2010 Mar; 495(1):8-13. PubMed ID: 19995547
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta suppressed Id-1 Expression in a smad3-dependent manner in LoVo cells.
Song H; Guo B; Zhang J; Song C
Anat Rec (Hoboken); 2010 Jan; 293(1):42-7. PubMed ID: 19798702
[TBL] [Abstract][Full Text] [Related]
7. Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture.
Alvarez J; Serra R
Dev Dyn; 2004 Aug; 230(4):685-99. PubMed ID: 15254903
[TBL] [Abstract][Full Text] [Related]
8. Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis.
Petersen M; Pardali E; van der Horst G; Cheung H; van den Hoogen C; van der Pluijm G; Ten Dijke P
Oncogene; 2010 Mar; 29(9):1351-61. PubMed ID: 20010874
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of TGF-β signaling, vasculogenic mimicry and proinflammatory gene expression by isoxanthohumol.
Serwe A; Rudolph K; Anke T; Erkel G
Invest New Drugs; 2012 Jun; 30(3):898-915. PubMed ID: 21340508
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of TGF-beta inhibitor is dependent on the microenvironment.
Medicherla S; Li L; Ma JY; Kapoun AM; Gaspar NJ; Liu YW; Mangadu R; O'Young G; Protter AA; Schreiner GF; Wong DH; Higgins LS
Anticancer Res; 2007; 27(6B):4149-57. PubMed ID: 18229422
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
Fink SP; Mikkola D; Willson JK; Markowitz S
Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756
[TBL] [Abstract][Full Text] [Related]
12. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
[TBL] [Abstract][Full Text] [Related]
14. Kinetic characterization of novel pyrazole TGF-beta receptor I kinase inhibitors and their blockade of the epithelial-mesenchymal transition.
Peng SB; Yan L; Xia X; Watkins SA; Brooks HB; Beight D; Herron DK; Jones ML; Lampe JW; McMillen WT; Mort N; Sawyer JS; Yingling JM
Biochemistry; 2005 Feb; 44(7):2293-304. PubMed ID: 15709742
[TBL] [Abstract][Full Text] [Related]
15. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
16. IGF-binding proteins mediate TGF-beta 1-induced apoptosis in bovine mammary epithelial BME-UV1 cells.
Gajewska M; Motyl T
Comp Biochem Physiol C Toxicol Pharmacol; 2004 Oct; 139(1-3):65-75. PubMed ID: 15556067
[TBL] [Abstract][Full Text] [Related]
17. TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling.
Felici A; Wurthner JU; Parks WT; Giam LR; Reiss M; Karpova TS; McNally JG; Roberts AB
EMBO J; 2003 Sep; 22(17):4465-77. PubMed ID: 12941698
[TBL] [Abstract][Full Text] [Related]
18. Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells.
Leivonen SK; Ala-Aho R; Koli K; Grénman R; Peltonen J; Kähäri VM
Oncogene; 2006 Apr; 25(18):2588-600. PubMed ID: 16407850
[TBL] [Abstract][Full Text] [Related]
19. Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor beta signaling.
Koinuma D; Tsutsumi S; Kamimura N; Taniguchi H; Miyazawa K; Sunamura M; Imamura T; Miyazono K; Aburatani H
Mol Cell Biol; 2009 Jan; 29(1):172-86. PubMed ID: 18955504
[TBL] [Abstract][Full Text] [Related]
20. 4-Dechloro-14-deoxy-oxacyclododecindione and 14-deoxy-oxacylododecindione, two inhibitors of inducible connective tissue growth factor expression from the imperfect fungus Exserohilum rostratum.
Richter J; Sandjo LP; Liermann JC; Opatz T; Erkel G
Bioorg Med Chem; 2015 Feb; 23(3):556-63. PubMed ID: 25537529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]